Home > Archive > 2008 >

Volume 27, Number 2 (June)

Dermatologic Conditions in Patients With Diabetes (pages 6-10)

Suraj Reddy, M.D., Jeffrey J. Meffert, M.D., Eric W. Kraus, M.D., and Larry E. Becker, M.D.

Roughly one-third of people with diabetes develop a dermatologic condition at some point in the course of the disease. This article shows you what these conditions look like and reviews the predisposing factors, presentation, diagnosis, and treatment of these common disorders.
Complications and comorbiditiesSkin complications

Insulin Resistance and Vascular Dysfunction (pages 12-16)

Eugenio Cersosimo, M.D.

Concomitant insulin resistance, vascular dysfunction, and inflammation are powerful factors in the development and progression of atherosclerosis that are often not targeted by conventional therapy. Dr. Cersosimo cogently illustrates the atherosclerotic process and proposes treatment strategies that should be considered beyond glycemic control.
Complications and comorbiditiesCardiovascular disease
Drug treatmentThiazolidinediones

Nonalcoholic Fatty Liver Disease: An Overlooked Complication of Type 2 Diabetes (pages 18-24)

Kenneth Cusi, M.D.

People with Type 2 diabetes are particularly susceptible to fatty liver disease, a frequent complication that requires special attention. Dr. Cusi reviews the pathophysiology, the increased risk of cardiovascular disease, primary-care screening, the challenge of diagnosis, and treatment options.
Complications and comorbiditiesLiver complications

In-Hospital Hyperglycemia (pages 25-34)

Adina Turcu, M.D., and Nancy J. Rennert, M.D.

Among hospitalized patients, more than 25% have diabetes and as many as 38% are hyperglycemic. In this thorough, exhaustive review, Drs. Turcu and Rennert cover everything you need to know to protect your patient from hyperglycemia in the hospital settingŲ¦rom glycemic goals to special situations to planning for discharge.
Surgery and hospital care
Management strategies and toolsStrategies for glycemic control

Glucose-Lowering Studies—Time to Move On (pages 35-36)

Charles A. Reasner, M.D.

The hot news in the diabetes world over the last three months was the shutdown of the glucose control arm of the ACCORD study. The results of that study as well as those of two other large studies will be presented at this year’s annual meeting of the ADA. Did we really need these studies? The Editor argues that our research dollars could have been better used by applying what we already know from an earlier large study.
Complications and comorbiditiesCardiovascular disease
Management strategies and toolsStrategies for glycemic control

The Art of Diabetes Education (pages 37-39)

Robert M. Anderson, Ed.D., and Martha M. Funnell, M.S., R.N., C.D.E.

Evidence-based theories about behavior change are necessary, but not sufficient, to diabetes education. Educators must understand those theories to implement sound interventions. But, argue two top educators, effective diabetes education also involves skills values, and traits that foster trust and openness.